Cancer Moonshot Round 2 Focuses On Screening; Pharma To Participate In New Summit
The initial moonshot aimed to increase cancer research while the reboot seeks to boost screenings to reduce death rate. New cancer cabinet mirrors previous task force. Biopharmaceutical companies are to participate in summit to highlight new commitments.